期刊文献+

糖尿病肾病患者维生素D结合蛋白水平及影响因素研究 被引量:7

Vitamin D Binding Protein Levels in Patients With Diabetic Nephropathy and Its Influencing Factors
下载PDF
导出
摘要 目的探讨糖尿病肾病(ON)患者维生素D结合蛋白(VDBP)水平及其影响因素,以明确VDBP与DN的关系,为DN的诊断及治疗提供新的依据。方法选取2013年8月-2014年2月在大连医科大学附属二院住院的2型糖尿病(T2DM)患者66例。根据尿微量清蛋白与尿肌酐比值(UACR)将患者分为3个亚组:正常清蛋白尿组(UACR〈30mg/g)、微量清蛋白尿组(UACR30-300mg/g)和临床清蛋白尿组(UACR〉300mg/g),各22例。同时选取该院门诊的健康体检者20例为健康对照组。采用酶联免疫吸附试验(ELISA)法检测4组受试者血、尿VDBP水平,同时检测其相关生化指标:空腹血糖(FPG)、糖化血红蛋白(HbA1c)、血尿素(UREA)、血肌酐(SCr)、总胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、血清蛋白(ALB)及尿微量清蛋白、尿肌酐。结果健康对照组及正常、微量、临床清蛋白尿组血VDBP水平分别为:(44.83±15.65)、(312.25±29.57)、(330.92±49.28)、(338.30±50.05)mg/L,4组间差异有统计学意义(F=409.42,P〈0.01);其中正常、微量、临床清蛋白尿组均高于健康对照组,差异有统计学意义(P〈0.05);而正常、微量及临床清蛋白尿3组比较,差异无统计学意义(P〉0.05)。健康对照组及正常、微量、临床清蛋白尿组尿VDBP水平分别为:(5.26±1.34)、(8.93±3.17)、(15.19±3.38)、(21.48±7.00)mg/L,4组间差异有统计学意义(F=58.66,P〈0.01);其中两两组间比较,差异均有统计学意义(P〈0.05)。因尿VDBP检测采用晨尿点标本,无24h尿标本检测准确,故依据UACR法,用尿肌酐对尿VDBP值进行校正(尿VDBP/Cr)。健康对照组与正常、微量、临床清蛋白尿组尿VDBP/Cr水平分别为:(4.25±1.89)、(10.76±7.02)、(23.01±11.39)、(41.58±17.10)mg/g,4组间差异有统计学意义(F=47.38,P〈0.01);其中两两组间比较,差异均有统计学意义(P〈0.05)。T2DM患者尿VDBP水平与估算肾小球滤过率(eGFR)呈负相关(r=一0.413,P:0.015)。另外,T2DM患者尿VDBP水平与UREA、SCr呈正相关(r值分别为0.505、0.454,P〈0.05);而与ALB呈负相关(r=一0.454,P〈0.05)。结论T2DM患者血、尿VDBP水平均有明显升高,且伴随DN的进展,尿VDBP水平逐渐升高,尿VDBP水平与eGFR、UREA、SCr、ALB有关,故尿VDBP水平对评估DN的病情有一定价值。 Objective To investigate vitamin D binding protein (VDBP) levels in patients with diabetic nephropathy (DN) , and to determine the relation between VDBP and DN, in order to provide new references for the diagnosis and treatment of DN. Methods We enrolled 66 T2DM patients who were admitted into the Second Affiliated Hospital of Dalian Medical University from August 2013 to February 2014. According to the ratio of UALB to UCR (UACR) , the patients were divided into three groups: normal albuminuria group (UACR 〈 30 mg/g) , slight albuminurla group (UACR 30~ 300 mg/g) and clinical albuminuria group ( UACR 〉 300 mg/g) , with 22 patients in each group. We also enrolled 20 healthy people who received outpatient service as control group. ELISA method was employed to detect the serum and urine VDBP level of the subjects, and biochemical indexes were measured, including FPG, HbA1c, UREA, SCr, TC, TG, HDL-C, LDL-C, ALB, UALB, UCR. Results The serum VDBP levels of control group, normal albuminuria group, slight albuminuria group and clinical alhuminuria group were (44. 83 ± 15.65), (312. 25 ±29.57), (330. 92±49. 28) and (338.30±50. 05) mg/L respectively, with significant differences among the four groups ( F = 409.42, P 〈 0. 01 ) ; normal albuminuria group, slight albuminuria group and clinical albuminuria group were higher than control group ( P 〈 0. 05 ) , while normal albuminuria group, slight albuminuria group and clinical albuminuria group were not significantly different ( P 〉 0.05 ) . The urine VDBP levels of control group, normal albuminuria group, slight albuminuria group and clinical albuminuria group were (5.26 ± 1.34 ), (8.93 ± 3.17), ( 15. 19± 3.38 ) and (21.48 ±7.00) mg/L, with significant differences among the four groups ( F = 58. 66, P 〈 0. 01 ) ; the pairwise comparison among the four groups showed significant differences ( P 〈 0.05 ) . Since urine VDBP test was made on urine samples taken in the morning, which leaded to poorer accuracy compared with 24 h urine samples, so UCR was used to adjust urine VDBP level by UACR method (urine VDBP/Cr) . The urine VDBP/Cr levels of control group, normal albuminuria group, slight albuminuria group and clinical albuminuria group were (4.25 ± 1. 89), ( 10.76±7.02), (23.01 ±11.39) and (41.58 ± 17.10) mg/g, with significant differences among the four groups (F =47.38, P 〈0.01); the pairwise comparison among the four groups showed significant differences (P 〈 0. 05 ) . The urine VDBP level of T2DM patients had negative correlation with eGFR in T2DM patients (r = -0. 413, P = 0. 015 ) . The urine VDBP level was positively correlated with UREA and SCr in T2DM patients ( r values were 0. 505 and 0. 454 ; P 〈 0.05 ) and were negatively correlated with ALB ( r = - 0. 454, P 〈 0. 05) . Conclusion T2DM patients have higher VDBP levels of serum and urine and see urine VDBP level increase as DN progresses, and urine VDBP level is related to eGFR, UREA, SCr and ALB, thus urine VDBP level has value in the assessment of DN to some extent.
出处 《中国全科医学》 CAS CSCD 北大核心 2015年第31期3812-3817,共6页 Chinese General Practice
基金 "十二五"国家科技支撑计划课题(2011BAI10B08)--血液净化质量改进和国产血液净化产品临床应用评价研究
关键词 糖尿病肾病 维生素D结合蛋白质 影响因素分析 Diabetic nephropathies Vitamin D -binding protein Root cause analysis
  • 相关文献

参考文献20

  • 1Cooke NE, Murgia A, McLeod JF. Vitamin D - bindingprotein. Structure and pattern of expression [ J ]. Ann N Y AcadSci, 1988, 538: 49-59.
  • 2Kisker 0,Onizuka S, Becker CM, et al. Vitamin D binding protein-macrophage activating factor ( DBP _ maf) inhibits angiogenesis andtumor growth in mice [ J] . Neoplasia,2003,5 (1 ) : 32 -40.
  • 3Kaneki M,Inoue S, Hosoi T,et al. Effects of 1 alpha,25 -dihydroxyvitamin D3 on macrophage colony - stimulating factorproduction and proliferation of human monocytic cells [ J ]. Blood,1994,83 (8) : 2285 -2293.
  • 4Mirkovic K, Doorenbos CR, Dam WA, et al. Urinary vitamin Dbinding protein ; a potential novel marker of renal interstitialinflammation and fibrosis [ J]. PLoS One, 2013 , 8 (2): e55887.
  • 5Uesugi N, Sakata N, Horiuchi S, et al. Glycoxidation - modifiedmacrophages and lipid peroxidation products are associated with theprogression of human diabetic nephropathy [ J]. Am J Kidney Dis,2001, 38 (5) : 1016 - 1025.
  • 6Chow FY, Nikolic - Paterson DJ, Atkins RC, et al. Macrophages instreptozotocin - induced diabetic nephropathy : potential role in renalfibrosis [ J ]. Nephrol Dial Transplant, 2004, 19 ( 12): 2987-2996.
  • 7Pratley RE, Thompson DB, Prochazka M, et al. An autosomal genomle scan for loci linked to prediabetic phenotypes in Pima Indians [J]. J ClinInvest, 1998, 101 (8): 1757-1764.
  • 8Wilson PW, Cupples LA, Meigs JB, et al. Genome scan for impairedglycemic status : results from the Framingham Heart Study [ J ].Diabetes, 1997, 46 (1) : 76.
  • 9Baier LJ, Dobberfuhl AM, Pratley RE, et al. Variations in thevitamin D - binding protein ( Gc locus) are associated with oralglucose tolerance in nondiabetic Pima Indians [ J]. J Clin EndocrinolMetab, 1998,83 (8) ; 2993 -2996.
  • 10Szathmary EJ. The effect of Gc genotype on fasting insulin level inDogrib Indians [J]. Hum Genet,1987, 75 (4) : 368 -372.

二级参考文献45

  • 1林善锬.重视糖尿病肾脏病变的诊断与治疗[J].中华内分泌代谢杂志,1998,14(2):65-67. 被引量:137
  • 2谭建明.成人胰岛细胞移植治疗糖尿病的现状与发展[J].中国实用内科杂志,2007,27(7):537-541. 被引量:10
  • 3Lansang MC, Hollenberg NK. Renal perfusion and the renal hemodynamic response to blocking the rennin system in diabetes.Are the forces leading to vasodilation and vasoconstriction linked.Diabetes, 2002,51: 2025-2028.
  • 4Miller JA, Curtis JR, Sochett EB. Relationship between diurnal blood pressure, renal hemodynamic function, and the renninangiotensin system in type 1 diabetes. Diabetes, 2003, 52:1806-1811.
  • 5Lane PH. Diabetic kidney disease: impact of puberty. Am J Physiol Renal Physiol, 2002,283: F589-F600.
  • 6White KE, Bilous RW, Marshall SM, et al. Podocyte number in normotensive type 1 diabetic patients with albuminuria. Diabetes,2002; 51: 3083-3089.
  • 7Kveder R, Kajtna KM, Rott T, et al. Nephrotic syndrome in patients with diabetes mellitus is not always associated with diabetic nephropathy. Nephrol Dial Transplant, 2001, 16 Suppl:86-87.
  • 8Haneda M, Koya D, Isono M, et al. Overview of glucose signaling in mesangial cells in diabetic nephropathy. J Am Soc Nephrol,2003,14: 1374-1382.
  • 9Evans JL, Goldfine ID, Maddux BA, et al. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2diabetes. Endocrine Reviews, 2002,23: 599-622.
  • 10Limaye PV, Raghuram N, Sivakami S. Oxidative stress and gene expression of antioxidant enzymes in the renal cortex of streptozotocin-induce diabetic rats. Mol cell biochem,2003,243:147-152.

共引文献265

同被引文献78

  • 1曹友德,李朝晖,李浩.糖尿病早期肾损伤患者尿视黄醇结合蛋白检测的临床意义[J].中国医学工程,2006,14(1):11-13. 被引量:10
  • 2王艳波,于永春,李智,李晶华,汪纯,王红玲.上海汉族人群维生素D结合蛋白基因多态性与2型糖尿病的相关分析[J].中华内分泌代谢杂志,2006,22(3):263-264. 被引量:1
  • 3PAL P B, SINHA K, SIL P C. Mangiferin attenuates diabetic ne- phropathy by inhibiting oxidative stress mediated signaling cascade, TNF alpha related and mitochondrial dependent apoptotic pathways in Streptozotocin-Induced diabetic rats [ J ]. PLoS One, 2014,9 ( 9 ) : 0107220.
  • 4World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complication[ J]. WHO/NCD/NCS, 1999, 31-32.
  • 5L|U Z H. Nephrology in China[ J]. Nat Rev Nephrol,2013,9 (9) : 523 -528.
  • 6BROWNLEE M. Biochemistry and molecular cell biology of diabetic complications [ J ]. Nature,2001,414 ( 6865 ) : 813-820.
  • 7SUSZTAK K, RAFF A C, SCHIFFER M, et al. Glucose-induced reac- tive oxygen species cause apoptosis of podocytes and podocyte deple- tion at the onset of diabetic nephropatby [ J ]. Diabetes,2006,55 ( 1 ) : 225-233.
  • 8ELMARAKBY A A,SULLIVAN J C. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy[ J ]. Card- iovase Ther,2012,30( 1 ) :49-59.
  • 9MORISHITA Y, HANAWA S, MIKI T, et al. The association of plas- ma prorenin level with an oxidative stress marker, 8-OHdG, in non- diabetic hemodialysis patients [ J ]. Clin Exp Nephrol, 2011,15 ( 3 ) : 398-404.
  • 10PAN H Z, ZHANG H, CHANG D, et al. The change of oxidative stress products in diabetes mellitus and diabetic retinopathy [ J ]. British Journal of Ophthalmology,2008,92 (4) :548-551.

引证文献7

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部